Citadel Advisors’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-899
| Closed | -$79K | – | 5842 |
|
|
2025
Q1 | $79K | Buy |
899
+740
| +465% | +$65K | ﹤0.01% | 5230 |
|
|
2024
Q4 | $14.7K | Buy |
+159
| New | +$14.7K | ﹤0.01% | 5687 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5796 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 5899 |
|
|
2023
Q3 | – | Sell |
-8,341
| Closed | -$5.01M | – | 5866 |
|
|
2023
Q2 | $5.01M | Buy |
+8,341
| New | +$5.01M | ﹤0.01% | 1716 |
|
|
2023
Q1 | – | Sell |
-44,626
| Closed | -$45.8M | – | 5908 |
|
|
2022
Q4 | $45.8M | Sell |
44,626
-1,533
| -3% | -$1.57M | 0.01% | 475 |
|
|
2022
Q3 | $26.8M | Buy |
46,159
+673
| +1% | +$391K | 0.01% | 671 |
|
|
2022
Q2 | $24.9M | Sell |
45,486
-39
| -0.1% | -$21.3K | 0.01% | 703 |
|
|
2022
Q1 | $29.2M | Sell |
45,525
-117
| -0.3% | -$75.1K | 0.01% | 682 |
|
|
2021
Q4 | $18.8M | Buy |
45,642
+76
| +0.2% | +$31.4K | ﹤0.01% | 972 |
|
|
2021
Q3 | $32.4M | Sell |
45,566
-577
| -1% | -$410K | 0.01% | 639 |
|
|
2021
Q2 | $35.5M | Buy |
+46,143
| New | +$35.5M | 0.01% | 647 |
|